Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.

Jianyuan ZhangXinming ZhaoYan ZhaoJingmian ZhangZhaoqi ZhangJianfang WangYingchen WangMeng DaiJingya Han

Published in: European journal of nuclear medicine and molecular imaging (2019)

The PET/CT-based radiomic features showed good performance in predicting EGFR mutation in non-small cell lung cancer, providing a useful method for the choice of targeted therapy in a clinical setting.

Keyphrases

pet ct
small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
positron emission tomography
lymph node metastasis
magnetic resonance imaging
squamous cell carcinoma
computed tomography
cell therapy
replacement therapy